Health IT Analytics July 18, 2019
Jessica Kent

Applying artificial intelligence technology to parts of the clinical trial process could increase trial success rates.

Artificial intelligence could improve key parts of the clinical trial process, including selection and recruitment and patient monitoring, according to a study published in Trends in Pharmacological Sciences.

It takes between 10 and 15 years and costs between $1.5 and $2.0 billion to bring a new drug to market, researchers noted, and about half of this time and capital is dedicated to clinical trials.

But despite significant investments, clinical trials still have high failure rates, the team stated.

Clinical trial failures are mainly due to poor recruiting and selecting techniques, as well as an inability to effectively monitor patients. Artificial intelligence tools...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Market Research, Pharma, Technology, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Katie Couric Talks Colon Cancer, Health Equity And AI
5 tips on AI adoption from a frontline physician champion
Survey of Oncologists Finds Agreement, Concerns Over AI Use

Share This Article